Skip to search boxSkip to navigationSkip to main content

Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice

  • Xianjun Luo
    ,
  • Honggui Li
    ,
  • Linqiang Ma
    ,
  • Jing Zhou
    ,
  • Xin Guo
    ,
  • Shih Lung Woo
*Corresponding author for this work
  • Texas A&M University
    ,
  • Chongqing Medical University
    ,
  • Sun Yat-Sen University
    ,
  • Baylor Scott & White Health
    ,
  • Augusta University
    ,
  • VA Medical Center
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background & Aims: Transmembrane protein 173 (TMEM173 or STING) signaling by macrophage activates the type I interferon-mediated innate immune response. The innate immune response contributes to hepatic steatosis and non-alcoholic fatty liver disease (NAFLD). We investigated whether STING regulates diet-induced in hepatic steatosis, inflammation, and liver fibrosis in mice. Methods: Mice with disruption of Tmem173 (STINGgt) on a C57BL/6J background, mice without disruption of this gene (controls), and mice with disruption of Tmem173 only in myeloid cells were fed a standard chow diet, a high-fat diet (HFD; 60% fat calories), or a methionine- and choline-deficient diet (MCD). Liver tissues were collected and analyzed by histology and immunohistochemistry. Bone marrow cells were isolated from mice, differentiated into macrophages, and incubated with 5,6-dimethylxanthenone-4-acetic acid (DMXAA; an activator of STING) or cyclic guanosine monophosphate–adenosine monophosphate (cGAMP). Macrophages or their media were applied to mouse hepatocytes or human hepatic stellate cells (LX2) cells, which were analyzed for cytokine expression, protein phosphorylation, and fat deposition (by oil red O staining after incubation with palmitate). We obtained liver tissues from patients with and without NAFLD and analyzed these by immunohistochemistry. Results: Non-parenchymal cells of liver tissues from patients with NAFLD had higher levels of STING than cells of liver tissues from patients without NAFLD. STINGgt mice and mice with disruption only in myeloid cells developed less severe hepatic steatosis, inflammation, and/or fibrosis after the HFD or MCD than control mice. Levels of phosphorylated c-Jun N-terminal kinase and p65 and mRNAs encoding tumor necrosis factor and interleukins 1B and 6 (markers of inflammation) were significantly lower in liver tissues from STINGgt mice vs control mice after the HFD or MCD. Transplantation of bone marrow cells from control mice to STINGgt mice restored the severity of steatosis and inflammation after the HFD. Macrophages from control, but not STINGgt, mice increased markers of inflammation in response to lipopolysaccharide and cGAMP. Hepatocytes and stellate cells cocultured with STINGgt macrophages in the presence of DMXAA or incubated with the medium collected from these macrophages had decreased fat deposition and markers of inflammation compared with hepatocytes or stellate cells incubated with control macrophages. Conclusions: Levels of STING were increased in liver tissues from patients with NAFLD and mice with HFD-induced steatosis. In mice, loss of STING from macrophages decreased the severity of liver fibrosis and the inflammatory response. STING might be a therapeutic target for NAFLD.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1971-1984.e4

Journal (Volume, Issue Number)

Gastroenterology (Volume 155, Issue 6)

Publication milestones

  • Published - 12/2018

Publication status

Published - 12/2018

ISSN

0016-5085

Publication IDs

  • Scopus: 85057555377
  • PubMed: 30213555
  • ORCID: /0000-0002-0305-4122/work/124760241

Publication metrics

Metrics

SciVal
FWCI
5.08
SciVal
Author count
21
SciVal
citations
58
SciVal
Paper percentile
98
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.05
Fractional count
20
Fractional count
0.95
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
395
Mentions
4
Captures
146

Funding Details

Funding This work was supported in whole or in part by grants from the American Diabetes Association (1-17-IBS-145) and the National Institutes of Health (DK095862) to Chaodong Wu. This work also was supported in part by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott & White, a VA Research Career Scientist Award, to Gianfranco Alpini and National Institutes of Health grants DK076898, DK110035, DK062975, AA025157, AA025997, and DK054811 to Gianfranco Alpini, Fanyin Meng, and Shannon Glaser, and by a VA Merit Award (1I01BX003031) and National Institutes of Health grant (DK108959) to Heather Francis. Also, Chaodong Wu is supported by the Hatch Program of the National Institutes of Food and Agriculture.
FundersFunding numbers
NIH
DK110035, AA025157, DK076898, AA025997, DK095862, DK062975, DK054811
ADA
1-17-IBS-145
VA
I01BX003031